181 related articles for article (PubMed ID: 34879057)
1. RB depletion is required for the continuous growth of tumors initiated by loss of RB.
Doan A; Arand J; Gong D; Drainas AP; Shue YT; Lee MC; Zhang S; Walter DM; Chaikovsky AC; Feldser DM; Vogel H; Dow LE; Skotheim JM; Sage J
PLoS Genet; 2021 Dec; 17(12):e1009941. PubMed ID: 34879057
[TBL] [Abstract][Full Text] [Related]
2. A role for Mediator complex subunit MED13L in Rb/E2F-induced growth arrest.
Angus SP; Nevins JR
Oncogene; 2012 Nov; 31(44):4709-17. PubMed ID: 22249253
[TBL] [Abstract][Full Text] [Related]
3. Suppression of melanotroph carcinogenesis leads to accelerated progression of pituitary anterior lobe tumors and medullary thyroid carcinomas in Rb+/- mice.
Zhou Z; Flesken-Nikitin A; Levine CG; Shmidt EN; Eng JP; Nikitina EY; Spencer DM; Nikitin AY
Cancer Res; 2005 Feb; 65(3):787-96. PubMed ID: 15705875
[TBL] [Abstract][Full Text] [Related]
4. Loss of E2F-1 reduces tumorigenesis and extends the lifespan of Rb1(+/-)mice.
Yamasaki L; Bronson R; Williams BO; Dyson NJ; Harlow E; Jacks T
Nat Genet; 1998 Apr; 18(4):360-4. PubMed ID: 9537419
[TBL] [Abstract][Full Text] [Related]
5. Regulation of RB transcription in vivo by RB family members.
Burkhart DL; Ngai LK; Roake CM; Viatour P; Thangavel C; Ho VM; Knudsen ES; Sage J
Mol Cell Biol; 2010 Apr; 30(7):1729-45. PubMed ID: 20100864
[TBL] [Abstract][Full Text] [Related]
6. PRMT5 competitively binds to CDK4 to promote G1-S transition upon glucose induction in hepatocellular carcinoma.
Yang H; Zhao X; Zhao L; Liu L; Li J; Jia W; Liu J; Huang G
Oncotarget; 2016 Nov; 7(44):72131-72147. PubMed ID: 27708221
[TBL] [Abstract][Full Text] [Related]
7. Loss of Rb-E2F repression results in caspase-8-mediated apoptosis through inactivation of focal adhesion kinase.
Lieman JH; Worley LA; Harbour JW
J Biol Chem; 2005 Mar; 280(11):10484-90. PubMed ID: 15640164
[TBL] [Abstract][Full Text] [Related]
8. DREAM and RB cooperate to induce gene repression and cell-cycle arrest in response to p53 activation.
Uxa S; Bernhart SH; Mages CFS; Fischer M; Kohler R; Hoffmann S; Stadler PF; Engeland K; Müller GA
Nucleic Acids Res; 2019 Sep; 47(17):9087-9103. PubMed ID: 31400114
[TBL] [Abstract][Full Text] [Related]
9. p27 and Rb are on overlapping pathways suppressing tumorigenesis in mice.
Park MS; Rosai J; Nguyen HT; Capodieci P; Cordon-Cardo C; Koff A
Proc Natl Acad Sci U S A; 1999 May; 96(11):6382-7. PubMed ID: 10339596
[TBL] [Abstract][Full Text] [Related]
10. Tandem E2F binding sites in the promoter of the p107 cell cycle regulator control p107 expression and its cellular functions.
Burkhart DL; Wirt SE; Zmoos AF; Kareta MS; Sage J
PLoS Genet; 2010 Jun; 6(6):e1001003. PubMed ID: 20585628
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of pituitary tumors in Rb mutant chimeras through E2f4 loss reveals a key suppressive role for the pRB/E2F pathway in urothelium and ganglionic carcinogenesis.
Parisi T; Bronson RT; Lees JA
Oncogene; 2009 Jan; 28(4):500-8. PubMed ID: 18997819
[TBL] [Abstract][Full Text] [Related]
12. E2F4 loss suppresses tumorigenesis in Rb mutant mice.
Lee EY; Cam H; Ziebold U; Rayman JB; Lees JA; Dynlacht BD
Cancer Cell; 2002 Dec; 2(6):463-72. PubMed ID: 12498715
[TBL] [Abstract][Full Text] [Related]
13. Inactivation of conditional Rb by Villin-Cre leads to aggressive tumors outside the gastrointestinal tract.
Kucherlapati MH; Nguyen AA; Bronson RT; Kucherlapati RS
Cancer Res; 2006 Apr; 66(7):3576-83. PubMed ID: 16585182
[TBL] [Abstract][Full Text] [Related]
14. Regulation of matrix metalloproteinase genes by E2F transcription factors: Rb-Raf-1 interaction as a novel target for metastatic disease.
Johnson JL; Pillai S; Pernazza D; Sebti SM; Lawrence NJ; Chellappan SP
Cancer Res; 2012 Jan; 72(2):516-26. PubMed ID: 22086850
[TBL] [Abstract][Full Text] [Related]
15. Integrated multi-omics analysis of RB-loss identifies widespread cellular programming and synthetic weaknesses.
Rajasekaran S; Siddiqui J; Rakijas J; Nicolay B; Lin C; Khan E; Patel R; Morris R; Wyler E; Boukhali M; Balasubramanyam J; Ranjith Kumar R; Van Rechem C; Vogel C; Elchuri SV; Landthaler M; Obermayer B; Haas W; Dyson N; Miles W
Commun Biol; 2021 Aug; 4(1):977. PubMed ID: 34404904
[TBL] [Abstract][Full Text] [Related]
16. Differential gene expression of p27Kip1 and Rb knockout pituitary tumors associated with altered growth and angiogenesis.
Chien WM; Garrison K; Caufield E; Orthel J; Dill J; Fero ML
Cell Cycle; 2007 Mar; 6(6):750-7. PubMed ID: 17361101
[TBL] [Abstract][Full Text] [Related]
17. ARF mutation accelerates pituitary tumor development in Rb+/- mice.
Tsai KY; MacPherson D; Rubinson DA; Nikitin AY; Bronson R; Mercer KL; Crowley D; Jacks T
Proc Natl Acad Sci U S A; 2002 Dec; 99(26):16865-70. PubMed ID: 12486224
[TBL] [Abstract][Full Text] [Related]
18. Inactivation of the retinoblastoma tumor suppressor induces apoptosis protease-activating factor-1 dependent and independent apoptotic pathways during embryogenesis.
Guo Z; Yikang S; Yoshida H; Mak TW; Zacksenhaus E
Cancer Res; 2001 Dec; 61(23):8395-400. PubMed ID: 11731416
[TBL] [Abstract][Full Text] [Related]
19. Regulation of BRCA1 expression by the Rb-E2F pathway.
Wang A; Schneider-Broussard R; Kumar AP; MacLeod MC; Johnson DG
J Biol Chem; 2000 Feb; 275(6):4532-6. PubMed ID: 10660629
[TBL] [Abstract][Full Text] [Related]
20. Mdm4 loss in mice expressing a p53 hypomorph alters tumor spectrum without improving survival.
Fang M; Simeonova I; Bardot B; Lejour V; Jaber S; Bouarich-Bourimi R; Morin A; Toledo F
Oncogene; 2014 Mar; 33(10):1336-9. PubMed ID: 23474762
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
